{"entity":{"type":"insider","cik":"0001626659","url":"/insider/0001626659","json_url":"/insider/0001626659.json","name":"HARGREAVES BRADLEY S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":28,"first":"2021-03-31","last":"2022-04-08","span_basis":"filed_date"},"name_variants":[{"name":"HARGREAVES BRADLEY S","source":"filing","n_filings":28,"first_seen":"2021-03-31","last_seen":"2022-04-08"}],"transactions":[{"id":6939548,"accession":"0001626659-22-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-22-000005","line_url":"/filing/0001626659-22-000005#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":5471647.0,"shares_owned_after_display":"5,471,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-08","scope":"insider"},{"id":6551308,"accession":"0001626659-22-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626659-22-000003","line_url":"/filing/0001626659-22-000003#line-2","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":54.0,"total_display":"54.00","total_whole":"54","shares_owned_after":5481947.0,"shares_owned_after_display":"5,481,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-08","scope":"insider"},{"id":6228666,"accession":"0001626659-22-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-22-000004","line_url":"/filing/0001626659-22-000004#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":54.0,"total_display":"54.00","total_whole":"54","shares_owned_after":5481647.0,"shares_owned_after_display":"5,481,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-11","scope":"insider"},{"id":6551304,"accession":"0001626659-22-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-22-000003","line_url":"/filing/0001626659-22-000003#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":1050.0,"total_display":"1,050.00","total_whole":"1,050","shares_owned_after":5482247.0,"shares_owned_after_display":"5,482,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-08","scope":"insider"},{"id":6310708,"accession":"0001626659-22-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-22-000002","line_url":"/filing/0001626659-22-000002#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":0.1486,"price_display":"0.15","price_state":"stated","total_value":1114.5,"total_display":"1,114.50","total_whole":"1,115","shares_owned_after":5489247.0,"shares_owned_after_display":"5,489,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":6460893,"accession":"0001626659-22-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-22-000001","line_url":"/filing/0001626659-22-000001#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.1845,"price_display":"0.18","price_state":"stated","total_value":922.5,"total_display":"922.50","total_whole":"923","shares_owned_after":5496747.0,"shares_owned_after_display":"5,496,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2022-01-03","scope":"insider"},{"id":5229684,"accession":"0001626659-21-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000025","line_url":"/filing/0001626659-21-000025#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.2,"price_display":"18.20","price_state":"stated","total_value":91000.0,"total_display":"91,000.00","total_whole":"91,000","shares_owned_after":5501747.0,"shares_owned_after_display":"5,501,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-21","scope":"insider"},{"id":5266584,"accession":"0001626659-21-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000024","line_url":"/filing/0001626659-21-000024#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4654.0,"shares_display":"4,654","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":884.26,"total_display":"884.26","total_whole":"884","shares_owned_after":5506747.0,"shares_owned_after_display":"5,506,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":5266578,"accession":"0001626659-21-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000023","line_url":"/filing/0001626659-21-000023#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.1713,"price_display":"0.17","price_state":"stated","total_value":3426.0,"total_display":"3,426.00","total_whole":"3,426","shares_owned_after":5511401.0,"shares_owned_after_display":"5,511,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":4833505,"accession":"0001626659-21-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000022","line_url":"/filing/0001626659-21-000022#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":5551401.0,"shares_owned_after_display":"5,551,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider"},{"id":4738772,"accession":"0001626659-21-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000021","line_url":"/filing/0001626659-21-000021#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":2200.0,"total_display":"2,200.00","total_whole":"2,200","shares_owned_after":5561401.0,"shares_owned_after_display":"5,561,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-10","scope":"insider"},{"id":5532774,"accession":"0001626659-21-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000020","line_url":"/filing/0001626659-21-000020#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":0.261,"price_display":"0.26","price_state":"stated","total_value":1696.5,"total_display":"1,696.50","total_whole":"1,697","shares_owned_after":5571401.0,"shares_owned_after_display":"5,571,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":5443415,"accession":"0001626659-21-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000019","line_url":"/filing/0001626659-21-000019#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":2550.0,"total_display":"2,550.00","total_whole":"2,550","shares_owned_after":5577901.0,"shares_owned_after_display":"5,577,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-08-02","scope":"insider"},{"id":5382513,"accession":"0001626659-21-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000016","line_url":"/filing/0001626659-21-000016#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":2550.0,"total_display":"2,550.00","total_whole":"2,550","shares_owned_after":5587901.0,"shares_owned_after_display":"5,587,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-29","scope":"insider"},{"id":5532771,"accession":"0001626659-21-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626659-21-000015","line_url":"/filing/0001626659-21-000015#line-2","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":351.0,"shares_display":"351","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":98.28,"total_display":"98.28","total_whole":"98","shares_owned_after":5597901.0,"shares_owned_after_display":"5,597,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-26","scope":"insider"},{"id":5532769,"accession":"0001626659-21-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000015","line_url":"/filing/0001626659-21-000015#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.245,"price_display":"0.24","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","total_whole":"2,450","shares_owned_after":5598252.0,"shares_owned_after_display":"5,598,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-26","scope":"insider"},{"id":5306064,"accession":"0001626659-21-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000014","line_url":"/filing/0001626659-21-000014#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2340.0,"total_display":"2,340.00","total_whole":"2,340","shares_owned_after":5608252.0,"shares_owned_after_display":"5,608,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider"},{"id":4577871,"accession":"0001626659-21-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000013","line_url":"/filing/0001626659-21-000013#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":5617252.0,"shares_owned_after_display":"5,617,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-28","scope":"insider"},{"id":4392021,"accession":"0001626659-21-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000012","line_url":"/filing/0001626659-21-000012#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":5625252.0,"shares_owned_after_display":"5,625,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-25","scope":"insider"},{"id":4278924,"accession":"0001626659-21-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626659-21-000011","line_url":"/filing/0001626659-21-000011#line-2","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":1450.0,"total_display":"1,450.00","total_whole":"1,450","shares_owned_after":5633252.0,"shares_owned_after_display":"5,633,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":4278918,"accession":"0001626659-21-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000011","line_url":"/filing/0001626659-21-000011#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":5638252.0,"shares_owned_after_display":"5,638,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":4945745,"accession":"0001626659-21-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000010","line_url":"/filing/0001626659-21-000010#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.2384,"price_display":"0.24","price_state":"stated","total_value":1192.0,"total_display":"1,192.00","total_whole":"1,192","shares_owned_after":5643252.0,"shares_owned_after_display":"5,643,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider"},{"id":4833502,"accession":"0001626659-21-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000009","line_url":"/filing/0001626659-21-000009#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":5648252.0,"shares_owned_after_display":"5,648,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-06-01","scope":"insider"},{"id":5010928,"accession":"0001626659-21-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001626659-21-000008","line_url":"/filing/0001626659-21-000008","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42150.0,"shares_display":"42,150","price_per_share":0.27762752075919334,"price_display":"0.28","price_state":"stated","total_value":11702.0,"total_display":"11,702.00","total_whole":"11,702","shares_owned_after":5653252.0,"shares_owned_after_display":"5,653,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-30","scope":"insider","n_lines":3},{"id":4909041,"accession":"0001626659-21-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626659-21-000007","line_url":"/filing/0001626659-21-000007#line-2","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2600.0,"total_display":"2,600.00","total_whole":"2,600","shares_owned_after":5695402.0,"shares_owned_after_display":"5,695,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-26","scope":"insider"},{"id":4909034,"accession":"0001626659-21-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000007","line_url":"/filing/0001626659-21-000007#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":5705402.0,"shares_owned_after_display":"5,705,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-26","scope":"insider"},{"id":5382511,"accession":"0001626659-21-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001626659-21-000006","line_url":"/filing/0001626659-21-000006#line-4","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24780.0,"shares_display":"24,780","price_per_share":0.265,"price_display":"0.26","price_state":"stated","total_value":6566.7,"total_display":"6,566.70","total_whole":"6,567","shares_owned_after":5730402.0,"shares_owned_after_display":"5,730,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-21","scope":"insider"},{"id":5382509,"accession":"0001626659-21-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001626659-21-000006","line_url":"/filing/0001626659-21-000006","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72562.0,"shares_display":"72,562","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":18140.5,"total_display":"18,140.50","total_whole":"18,141","shares_owned_after":5777744.0,"shares_owned_after_display":"5,777,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider","n_lines":3},{"id":5166648,"accession":"0001626659-21-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000005","line_url":"/filing/0001626659-21-000005#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23500.0,"shares_display":"23,500","price_per_share":0.222,"price_display":"0.22","price_state":"stated","total_value":5217.0,"total_display":"5,217.00","total_whole":"5,217","shares_owned_after":5827744.0,"shares_owned_after_display":"5,827,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-16","filed_date":"2021-04-19","scope":"insider"},{"id":4646133,"accession":"0001626659-21-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000004","line_url":"/filing/0001626659-21-000004#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.2314,"price_display":"0.23","price_state":"stated","total_value":4628.0,"total_display":"4,628.00","total_whole":"4,628","shares_owned_after":5851244.0,"shares_owned_after_display":"5,851,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-07","scope":"insider"},{"id":4833498,"accession":"0001626659-21-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000002","line_url":"/filing/0001626659-21-000002#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technolgy & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technolgy & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18911.0,"shares_display":"18,911","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":5105.97,"total_display":"5,105.97","total_whole":"5,106","shares_owned_after":5871244.0,"shares_owned_after_display":"5,871,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-31","scope":"insider"},{"id":5229680,"accession":"0001626659-21-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000001","line_url":"/filing/0001626659-21-000001#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technolgy & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technolgy & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19700.0,"shares_display":"19,700","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":5910.0,"total_display":"5,910.00","total_whole":"5,910","shares_owned_after":5890155.0,"shares_owned_after_display":"5,890,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-21","filed_date":"2021-03-31","scope":"insider"},{"id":4432243,"accession":"0001626659-21-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626659-21-000003","line_url":"/filing/0001626659-21-000003#line-1","is_derivative":false,"issuer_cik":"0001493712","issuer_name":"Cell MedX Corp.","issuer_ticker":"CMXC","issuer_name_source":null,"issuer_url":"/issuer/0001493712","owner_cik":"0001626659","owner_name":"HARGREAVES BRADLEY S","owner_display_name":"HARGREAVES BRADLEY S","owner_url":"/insider/0001626659","role":"Director, Officer (VP Technology & Operations), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technology & Operations","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.218,"price_display":"0.22","price_state":"stated","total_value":5450.0,"total_display":"5,450.00","total_whole":"5,450","shares_owned_after":5909855.0,"shares_owned_after_display":"5,909,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-21","filed_date":"2021-03-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001493712","name":"Cell MedX Corp.","url":"/issuer/0001493712","role":"Director, Officer (VP Technology & Operations), Ten percent owner","n_filings":28,"first_seen":"2021-03-31","last_seen":"2022-04-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001626659","retrieved_at":"2026-08-26T02:03:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}